SLC16A3 and lung adenocarcinoma: Importantly, SYVN1 was identified as an E3 ubiquitin ligase that catalyses the nonproteolytic ubiquitylation of MCT4, which regulates glycolytic metabolism and thus controls cell proliferation and the progression of lung adenocarcinoma (LUAD).